Back to Markets

JNJ vs MRK

A side-by-side look at JNJ and MRK, updated throughout the trading session.

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…
Live figures are refreshing. Check back in a moment.

JNJ vs MRK: how they differ

Johnson & Johnson (JNJ) and Merck & Co., Inc. (MRK) are both in the Healthcare sector, in the same Drug Manufacturers - General industry. Both trade on NYSE.

JNJ trades about 7.6 million shares a day on average, against 10.3 million for MRK. Their betas are similar (0.23 for JNJ, 0.22 for MRK). Over the trailing twelve months, JNJ paid $5.28 per share in dividends and MRK paid $3.40 per share.

Figures as of October 26, 2026.

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.